Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.

[1]  Ajay N. Jain,et al.  High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. , 2003, The American journal of pathology.

[2]  Samuel Singer,et al.  PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors , 2003, Science.

[3]  David Botstein,et al.  The Stanford Microarray Database: data access and quality assessment tools , 2003, Nucleic Acids Res..

[4]  M. Bittner,et al.  Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. , 2002, The American journal of pathology.

[5]  H. Ihn,et al.  Mitogenic activity of dermatofibrosarcoma protuberans is mediated via an extracellular signal related kinase dependent pathway. , 2002, The Journal of investigative dermatology.

[6]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Eary,et al.  Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[9]  C. Antonescu,et al.  Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans , 2002, International journal of cancer.

[10]  D. Botstein,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[11]  O. Haas,et al.  Felix Mitelman: Database of chromosome aberrations in cancer , 2002, Human Genetics.

[12]  E. Calonje.  Tumors of the Soft Tissues. Atlas of Tumor Pathology: Third Series, Fascicle 30 , 2002 .

[13]  E. Lander,et al.  Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.

[14]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[15]  西尾 淳.  Overrepresentation of 17q22～qter and 22q13 in dermatofibrosarcoma protuberans but not in dermatofibroma : a comparative genomic hybridization study , 2002 .

[16]  E. Lander,et al.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.

[17]  P S Meltzer,et al.  Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile. , 2001, Cancer research.

[18]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Y. Kaneko,et al.  Supernumerary ring chromosomes in dermatofibrosarcoma protuberans may contain sequences from 8q11.2-qter and 17q21-qter: a combined cytogenetic and comparative genomic hybridization study. , 2001, Cancer genetics and cytogenetics.

[21]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[22]  J. Kere,et al.  Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans , 2001, Cytogenetic and Genome Research.

[23]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[24]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Kempson,et al.  Tumors of the soft tissues , 2001 .

[26]  Marc J. van de Vijver,et al.  Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers , 2000, Nature Genetics.

[27]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[28]  Jonathan J. Lewis,et al.  Dermatofibrosarcoma protuberans , 2000, Cancer.

[29]  C. Steidl,et al.  Characterization of the human and mouse HEY1, HEY2, and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family. , 2000, Genomics.

[30]  B. Sikic,et al.  Clinical studies of antisense therapy in cancer. , 2000, Frontiers in bioscience : a journal and virtual library.

[31]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[32]  M. van de Rijn,et al.  Immunoblot analysis of CD34 expression in histologically diverse neoplasms. , 2000, The American journal of pathology.

[33]  J. Nemunaitis,et al.  Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  T. Sjöblom,et al.  The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. , 1999, Cancer research.

[35]  E. Repasky,et al.  Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells. , 1999, Experimental cell research.

[36]  P. Rigby,et al.  Mox2 is a component of the genetic hierarchy controlling limb muscle development , 1999, Nature.

[37]  Manfred Gessler,et al.  Hey genes: a novel subfamily of hairy- and Enhancer of split related genes specifically expressed during mouse embryogenesis , 1999, Mechanisms of Development.

[38]  F. Mitelman,et al.  Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group. , 1999, The American journal of pathology.

[39]  Tony Pawson,et al.  Mammalian Grb2 Regulates Multiple Steps in Embryonic Development and Malignant Transformation , 1998, Cell.

[40]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Bittner,et al.  Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.

[42]  J. Fletcher,et al.  Various regions within the alpha‐helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant‐cell fibroblastomas , 1998, Genes, chromosomes & cancer.

[43]  G. Sozzi,et al.  Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans , 1998, Oncogene.

[44]  C. Heldin,et al.  Signal transduction via platelet-derived growth factor receptors. , 1998, Biochimica et biophysica acta.

[45]  H. Suit,et al.  Benign and low-grade tumors of the soft tissues: role for radiation therapy. , 1997, Cancer treatment and research.

[46]  J. Dumanski,et al.  Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatof ibrosarcoma protuberans and giant-cell fibroblastoma , 1997, Nature Genetics.

[47]  C. Wright,et al.  Differential localization of Mox-1 and Mox-2 proteins indicates distinct roles during development. , 1996, The International journal of developmental biology.

[48]  N. Penneys.  Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22 , 1996 .

[49]  D. Leszczyński,et al.  Protein kinase C-α regulates proliferation but not apoptosis in rat coronary vascular smooth muscle cells , 1996 .

[50]  A. Carbone,et al.  KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas. , 1995, American journal of clinical pathology.

[51]  J Piper,et al.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.

[52]  F. Hecht,et al.  Supernumerary ring chromosomes containing chromosome 17 sequences. A specific feature of dermatofibrosarcoma protuberans? , 1994, Cancer genetics and cytogenetics.

[53]  R. Warnke,et al.  Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. , 1993, Blood.

[54]  J. Nadeau,et al.  Mox-1 and Mox-2 define a novel homeobox gene subfamily and are differentially expressed during early mesodermal patterning in mouse embryos. , 1992, Development.

[55]  H. Tagami,et al.  Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34 , 1992, The British journal of dermatology.

[56]  F. Mitelman,et al.  Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans. , 1990, Cancer genetics and cytogenetics.

[57]  A. Sandberg,et al.  Cytogenetic analysis of dermatofibrosarcoma protuberans. , 1990, Cancer genetics and cytogenetics.

[58]  David Siegmund,et al.  Confidence Sets in Change-point Problems , 1988 .

[59]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .